Aclaris Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Millennium Management LLC(4.2%),Millennium Group Management LLC(4.2%)等
Aclaris Therapeutics | 4:持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 4:持股变动声明-高管 Balthaser Kevin
Aclaris Therapeutics | 4:持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 4:持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 10-Q:2024财年二季报
Aclaris Therapeutics | 8-K:Aclaris Therapeutics公布2024年第二季度财务业绩并提供公司最新情况
Aclaris Therapeutics | 4:持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 8-K:重大事件
Aclaris Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(2.9%)
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-高管 Walker Neal
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-股东 Leonard Braden Michael
Aclaris Therapeutics | 4:持股变动声明-董事 Humphries William D.
Aclaris Therapeutics | 4:持股变动声明-董事 MILANO VINCENT
暂无数据
暂无数据